Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in Patients With ARDS

Clinical trial NCT05241067 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05241067
Sponsor: Pharmazz, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Respiratory Distress Syndrome (ARDS)

Start date: 2026-05-01
Primary completion: 2026-10-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.